Correlation Engine 2.0
Clear Search sequence regions

  • amino acid (1)
  • cellular (1)
  • ctm (1)
  • impairment (1)
  • mice (1)
  • mutant proteins (2)
  • pathogenesis (1)
  • prion (3)
  • prions (2)
  • protein transport (1)
  • PrP C (1)
  • reticulum (1)
  • Sizes of these terms reflect their relevance to your search.

    The mechanism by which pathogenic mutations in the globular domain of the cellular prion protein (PrP(C)) increase the likelihood of misfolding and predispose to diseases is not yet known. Differences in the evidences provided by structural and metabolic studies of these mutants suggest that in vivo folding could be playing an essential role in their pathogenesis. To address this role, here we use the single or combined M206S and M213S artificial mutants causing labile folds and express them in cells. We find that these mutants are highly toxic, fold as transmembrane PrP, and lack the intramolecular disulfide bond. When the mutations are placed in a chain with impeded transmembrane PrP formation, toxicity is rescued. These results suggest that oxidative folding impairment, as on aging, can be fundamental for the genesis of intracellular neurotoxic intermediates key in prion neurodegenerations.


    Silvia Lisa, Beatriz Domingo, Javier Martínez, Sabine Gilch, Juan F Llopis, Hermann M Schätzl, María Gasset. Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms. The Journal of biological chemistry. 2012 Oct 26;287(44):36693-701

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 22955286

    View Full Text